Lymphatic system in human dilated cardiomyopathy

C Marchetti1, P Poggi, A Calligaro

  • 1Istituto di Istologia ed Embriologia Generale, Università di Pavia, Italia.

Journal of Submicroscopic Cytology and Pathology
|October 1, 1988
PubMed

Insights

Dilated cardiomyopathy affects heart lymph capillaries, causing dilation in edematous areas and scarcity in fibrotic regions. This suggests the lymphatic system responds differently to tissue changes in heart disease.

Area of Science:

  • Cardiovascular Research
  • Lymphatic System Biology
  • Pathology

Background:

  • Dilated cardiomyopathy is a significant cause of heart failure.
  • The role of the lymphatic system in cardiac pathology is not fully understood.
  • Previous research has not detailed lymph capillary morphology in dilated cardiomyopathy.

Purpose of the Study:

  • To investigate the morphological characteristics of lymph capillaries in human hearts with dilated cardiomyopathy.
  • To compare these features in edematous versus fibrotic myocardial regions.
  • To correlate in-vivo observations with experimental models of impaired lymph flow.

Main Methods:

  • Human heart tissue samples from dilated cardiomyopathy patients were examined.
  • Morphological analysis of lymph capillaries was performed.
  • Experimental models were used to induce lymph flow damage in myocardium.

Main Results:

  • Edematous myocardial regions showed dilated lymph capillaries with indented endothelial walls and more open intercellular junctions.
  • Fibrotic myocardial areas exhibited scanty and subtle lymph capillaries.
  • Observed changes in dilated cardiomyopathy hearts resemble those seen in experimental lymph flow impairment.

Conclusions:

  • Lymph capillary morphology differs significantly between edematous and fibrotic areas in dilated cardiomyopathy.
  • The lymphatic system demonstrates a differential response to altered myocardial tissue and interstitial conditions.
  • These findings highlight the lymphatic system's involvement in the pathophysiology of dilated cardiomyopathy.

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...